News

Testimonials, success stories, grants and more...

At OBBI, we focus on enabling groundbreaking advancements on organoids, to drive innovation in research, diagnostics, and therapeutic development.

Dr. Danièle Noël, Research Director at IRMB, will be speaking at Biotherapy Days 2026 in Toulouse—the premier gathering for the biotherapy and bioproduction community in Occitanie. As part of her talk, she will present the OBBI initiative, offering valuable visibility...
OBBI is an active member of the Réseau des Intégrateurs Biothérapie–Bioproduction, a national network of platforms labeled under France 2030. This network fosters collaboration between integrators across France, aiming to accelerate the development and industrialization of advanced biotherapies....
OBBI receives support from the University of Montpellier’s Innovation Hub (PUI) through the IN-Lab Engineering program. This initiative strengthens strategic development within academic platforms, enhancing OBBI’s ability to advance projects, build industrial partnerships, and promote organoid and extracellular vesicle technologies....
OBBI is supported by CeBBOc, a regional initiative dedicated to strengthening the biotherapies sector in Occitanie. Through the co-funding of OBBI’s Business Development role, CeBBOc helps drive partnerships and the transfer of organoid and extracellular vesicle technologies to industry and...
OBBI is supported by France 2030, the national investment program accelerating innovation in strategic sectors such as health and biotherapies. As a designated Biotherapy–Bioproduction Integrator, OBBI leverages this support to expand its organoid and extracellular vesicle production capacities, invest in...
OBBI will be present at Innovative Therapies Days, a key event dedicated to cutting-edge advances in biotherapies and regenerative medicine. We look forward to sharing our expertise and connecting with industry and academic leaders....
OBBI will take part in the upcoming AFSSI Connexions, the annual event for France’s innovative health technology sector. We look forward to showcasing our expertise in the bioproduction of organoids and extracellular vesicles, and to engaging with academic, industrial, and...
OBBI has made a significant breakthrough by producing exosomal particles of specific sizes. This achievement is essential for developing advanced home technology that can accurately measure particle sizes at the nanoscale....
OBBI Integrator
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.